Insider Transactions in Q4 2022 at Recursion Pharmaceuticals, Inc. (RXRX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
99,754
+0.84%
|
$698,278
$7.55 P/Share
|
|
Dec 29
2022
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
84,622
+0.72%
|
$592,354
$7.71 P/Share
|
|
Dec 29
2022
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
8,000
-3.78%
|
$56,000
$7.7 P/Share
|
|
Dec 29
2022
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+3.64%
|
$8,000
$1.06 P/Share
|
|
Dec 28
2022
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
71,299
+0.61%
|
$499,093
$7.18 P/Share
|
|
Dec 27
2022
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
145,652
+1.25%
|
$1,019,564
$7.24 P/Share
|
|
Dec 27
2022
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$62,195
$7.25 P/Share
|
|
Dec 23
2022
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,378
+0.87%
|
$702,646
$7.52 P/Share
|
|
Dec 15
2022
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-11.34%
|
$80,000
$8.85 P/Share
|
|
Dec 15
2022
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.37%
|
$10,000
$2.22 P/Share
|
|
Dec 14
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.57%
|
-
|
|
Dec 13
2022
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$71,080
$8.96 P/Share
|
|
Dec 01
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$22,500
$9.27 P/Share
|
|
Dec 01
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Dec 01
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
37,210
-3.09%
|
$334,890
$9.03 P/Share
|
|
Dec 01
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+2.98%
|
-
|
|
Dec 01
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+4.94%
|
$62,500
$2.48 P/Share
|
|
Nov 29
2022
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$71,080
$8.75 P/Share
|
|
Nov 17
2022
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
16,000
-7.28%
|
$160,000
$10.96 P/Share
|
|
Nov 17
2022
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+6.79%
|
$16,000
$1.06 P/Share
|
|
Nov 16
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.56%
|
-
|
|
Nov 16
2022
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
17,770
-0.23%
|
$195,470
$11.12 P/Share
|
|
Nov 15
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,751
-1.0%
|
$63,261
$11.86 P/Share
|
|
Nov 15
2022
|
Michael Secora Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,065
-0.18%
|
$11,715
$11.86 P/Share
|
|
Nov 15
2022
|
Tina Marriott Larson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,453
-0.71%
|
$15,983
$11.86 P/Share
|
|
Nov 15
2022
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.52%
|
$120,000
$12.31 P/Share
|
|
Nov 15
2022
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.09%
|
$10,000
$2.22 P/Share
|
|
Nov 15
2022
|
Shafique Virani Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-0.69%
|
$6,743
$11.86 P/Share
|
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$25,000
$10.1 P/Share
|
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,693
-3.09%
|
$366,930
$10.0 P/Share
|
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.02%
|
-
|
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+5.0%
|
$62,500
$2.48 P/Share
|
|
Oct 27
2022
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
2,551,020
+18.43%
|
$22,959,180
$9.8 P/Share
|
|
Oct 27
2022
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
16,000
-7.24%
|
$160,000
$10.72 P/Share
|
|
Oct 27
2022
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+6.75%
|
$16,000
$1.06 P/Share
|
|
Oct 19
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.56%
|
-
|
|
Oct 14
2022
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.2%
|
$100,000
$10.92 P/Share
|
|
Oct 14
2022
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.82%
|
$10,000
$2.22 P/Share
|
|
Oct 06
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$27,500
$11.64 P/Share
|
|
Oct 06
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Oct 06
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,053
-3.1%
|
$396,583
$11.58 P/Share
|
|
Oct 06
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.08%
|
-
|
|
Oct 06
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+5.11%
|
$62,500
$2.48 P/Share
|
|
Oct 03
2022
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,092
+0.18%
|
-
|
|
Oct 03
2022
|
R. Martin Chavez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,725
+4.94%
|
-
|
|
Oct 03
2022
|
Terry Ann Burrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,265
+0.8%
|
-
|
|
Oct 03
2022
|
Blake Borgeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
920
+0.01%
|
-
|
|
Oct 03
2022
|
Zachary Bogue Director |
BUY
Grant, award, or other acquisition
|
Direct |
977
+16.38%
|
-
|